Related Experiment Video
Updated: Apr 26, 2026

Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Published on: July 8, 2025
Differing effects when using phenylephrine and norepinephrine to augment cerebral blood flow after traumatic brain
Stuart H Friess1, Benjamin Bruins, Todd J Kilbaugh
11 Department of Pediatrics, Washington University in St. Louis School of Medicine , St. Louis, Missouri.
Insights
Phenylephrine (PE) improved outcomes more than norepinephrine (NE) in swine models of traumatic brain injury (TBI). PE reduced cell injury and metabolic crisis, suggesting it may be a better vasopressor for TBI management.
Area of Science:
- Neuroscience
- Trauma Surgery
- Pediatric Critical Care
Background:
- Low cerebral blood flow (CBF) after traumatic brain injury (TBI) in children is linked to poor outcomes.
- Cerebral perfusion pressure (CPP) support is used to treat cerebral hypoperfusion, but vasopressor efficacy is unclear.
Purpose of the Study:
- To compare the efficacy of phenylephrine (PE) and norepinephrine (NE) in supporting CPP and improving outcomes after TBI in a pediatric swine model.
Main Methods:
- Sixteen 4-week-old swine experienced nonimpact inertial TBI.
- Intraparenchymal monitors measured ICP, CBF, PbtO2, and microdialysis.
- Animals received PE or NE infusions to maintain CPP > 70 mm Hg for 5 hours post-injury.
Main Results:
- Both PE and NE increased CBF similarly, with no difference in ICP.
- NE resulted in higher PbtO2 than PE, but PE led to a greater reduction in metabolic crisis (lactate/pyruvate ratio).
- PE-supported CPP augmentation showed significantly smaller cell injury volumes compared to NE.
Conclusions:
- Despite similar CBF increases, NE resulted in greater hypoxic-ischemic injury than PE.
- PE may be a more effective vasopressor for CPP augmentation in pediatric TBI compared to NE.
- Further clinical trials are needed to compare vasopressor effectiveness in TBI management.
Abstract:
Low cerebral blood flow (CBF) states have been demonstrated in children early after traumatic brain injury (TBI), and have been correlated with poorer outcomes. Cerebral perfusion pressure (CPP) support following severe TBI is commonly implemented to correct cerebral hypoperfusion, but the efficacy of various vasopressors has not been determined. Sixteen 4-week-old female swine underwent nonimpact inertial brain injury in the sagittal plane. Intraparenchymal monitors were placed to measure intracranial pressure (ICP), CBF, brain tissue oxygen tension (PbtO2), and cerebral microdialysis 30 min to 6 h post-injury. One hour after injury, animals were randomized to receive either phenylephrine (PE) or norepinephrine (NE) infusions titrated to a CPP>70 mm Hg for 5 h. Animals were euthanized 6 h post-TBI, and brains were fixed and stained to assess regions of cell and axonal injury. After initiation of CPP augmentation with NE or PE infusions, there were no differences in ICP between the groups or over time. Animals receiving NE had higher PbtO2 than those receiving PE (29.6±10.2 vs. 19.6±6.4 torr at 6 h post-injury, p<0.05). CBF increased similarly in both the NE and PE groups. CPP support with PE resulted in a greater reduction in metabolic crisis than with NE (lactate/pyruvate ratio 16.7±2.4 vs. 42.7±10.2 at 6 h post-injury, p<0.05). Augmentation of CPP to 70 mm Hg with PE resulted in significantly smaller cell injury volumes at 6 h post-injury than CPP support with NE (0.4% vs. 1.4%, p<0.05). Despite similar increases in CBF, CPP support with NE resulted in greater brain tissue oxygenation and hypoxic-ischemic injury than CPP support with PE. Future clinical studies comparing the effectiveness of various vasopressors for CPP support are warranted.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology

